InteRNA Technologies announced today the recent publication of data from a collaboration with University Medical Center (UMC) Utrecht in Journal of Neuroscience showing that the downregulation of miR-135a levels can reduce seizure activity after the onset of spontaneous recurrent seizures (SRS) in chronic-stage Mesial Temporal Lobe Epilepsy (mTLE) in mouse models. miR-135 is a microRNA (miRNA) known to control neuronal morphology and synaptic function that is upregulated in neurons in the epileptic brain.
All experts in the field of regenerative medicine and stem cell research are situated on one location at the Utrecht Science Park, in the Regenerative Medicine Center Utrecht (RMCU). Regenerative medicine is a promising field of interest, where scientists do research with the aim to restore the structure and function of damaged tissue and organs.
Utrecht Science Park is the beating heart of Europe's most competitive region. We bring competence from business, industry and academia together in order to design and create healthier, safer and more sustainable cities for today and for subsequent generations.
Utrecht Science Park provides a vibrant, dynamic and exciting place to work, to study and to interact